Quadrant Biosciences names Tessier general counsel

SYRACUSE — Quadrant Biosciences Inc., a molecular diagnostics company, announced that Wakaba Tessier has joined as its general counsel. 

She will be providing strategic and practical advice to senior leadership as the Syracuse–based company navigates the health-care system. Tessier was most recently a partner at Husch Blackwell LLP, a law firm with two dozen offices across the country.

During her tenure at Husch Blackwell, Tessier’s practice focused on state and federal health-privacy law, federal fraud and abuse issues related to the Stark Law, the False Claims Act and the Anti-Kickback Statute, and complex issues facing pharmacies and laboratories. She also led various business-development initiatives and associate-recruiting activities on behalf of the firm. Tessier earned a bachelor’s degree from Wellesley College and her law degree from Washington University in St. Louis School of Law.

 “I’m thrilled to have someone of Wakaba’s caliber and experience join our senior management team as General Counsel,” said Richard Uhlig, Quadrant founder and CEO, said in a news release. “She is a highly experienced legal executive with a strong background in the healthcare system, and I am confident that she will be an outstanding addition to our management team.”

Quadrant Biosciences says it is a life-science company “developing epigenetic diagnostic solutions for large-scale health issues.” The company has entered into collaborative research relationships with institutions such as Upstate Medical University and Penn State University to explore and develop novel biomarker technologies with a focus on Autism Spectrum Disorder, concussion, and Parkinson’s disease. Recently, it has leveraged its expertise in RNA analysis to address the COVID-19 pandemic. Quadrant’s Clarifi COVID-19 saliva test, co-developed by Upstate Medical, received emergency use authorization by the FDA in September 2020.

SYRACUSE — Quadrant Biosciences Inc., a molecular diagnostics company, announced that Wakaba Tessier has joined as its general counsel. 

She will be providing strategic and practical advice to senior leadership as the Syracuse–based company navigates the health-care system. Tessier was most recently a partner at Husch Blackwell LLP, a law firm with two dozen offices across the country.

During her tenure at Husch Blackwell, Tessier’s practice focused on state and federal health-privacy law, federal fraud and abuse issues related to the Stark Law, the False Claims Act and the Anti-Kickback Statute, and complex issues facing pharmacies and laboratories. She also led various business-development initiatives and associate-recruiting activities on behalf of the firm. Tessier earned a bachelor’s degree from Wellesley College and her law degree from Washington University in St. Louis School of Law.

 “I’m thrilled to have someone of Wakaba’s caliber and experience join our senior management team as General Counsel,” said Richard Uhlig, Quadrant founder and CEO, said in a news release. “She is a highly experienced legal executive with a strong background in the healthcare system, and I am confident that she will be an outstanding addition to our management team.”

Quadrant Biosciences says it is a life-science company “developing epigenetic diagnostic solutions for large-scale health issues.” The company has entered into collaborative research relationships with institutions such as Upstate Medical University and Penn State University to explore and develop novel biomarker technologies with a focus on Autism Spectrum Disorder, concussion, and Parkinson’s disease. Recently, it has leveraged its expertise in RNA analysis to address the COVID-19 pandemic. Quadrant’s Clarifi COVID-19 saliva test, co-developed by Upstate Medical, received emergency use authorization by the FDA in September 2020.